Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · IEX Real-Time Price · USD
14.57
-0.16 (-1.09%)
May 17, 2024, 4:00 PM EDT - Market closed

Cross Country Healthcare Revenue

Cross Country Healthcare had revenue of $1.78B in the twelve months ending March 31, 2024, down -32.73% year-over-year. Revenue in the quarter ending March 31, 2024 was $379.17M, a -39.11% decrease year-over-year. In the year 2023, Cross Country Healthcare had annual revenue of $2.02B, a decrease of -28.04%.

Revenue (ttm)
$1.78B
Revenue Growth
-32.73%
P/S Ratio
0.29
Revenue / Employee
$135,267
Employees
13,131
Market Cap
506.66M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.02B-786.88M-28.04%
Dec 31, 20222.81B1.13B67.39%
Dec 31, 20211.68B840.24M100.46%
Dec 31, 2020836.42M14.19M1.73%
Dec 31, 2019822.22M5.74M0.70%
Dec 31, 2018816.48M-48.56M-5.61%
Dec 31, 2017865.05M31.51M3.78%
Dec 31, 2016833.54M66.12M8.62%
Dec 31, 2015767.42M149.60M24.21%
Dec 31, 2014617.83M179.51M40.96%
Dec 31, 2013438.31M-4.32M-0.98%
Dec 31, 2012442.64M3.26M0.74%
Dec 31, 2011439.38M32.77M8.06%
Dec 31, 2010406.60M-171.63M-29.68%
Dec 31, 2009578.24M-156.01M-21.25%
Dec 31, 2008734.25M15.97M2.22%
Dec 31, 2007718.27M63.12M9.63%
Dec 31, 2006655.15M9.76M1.51%
Dec 31, 2005645.39M-8.72M-1.33%
Dec 31, 2004654.11M-18.99M-2.82%
Dec 31, 2003673.10M46.99M7.51%
Dec 31, 2002626.11M121.75M24.14%
Dec 31, 2001504.36M136.03M36.93%
Dec 31, 2000368.33M280.60M319.86%
Dec 31, 199987.73M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Community Health Systems 12.52B
Aveanna Healthcare Holdings 1.92B
InnovAge Holding 741.33M
Surmodics 142.96M
Y-mAbs Therapeutics 84.50M
MaxCyte 44.05M
Cibus 2.32M
Revenue Rankings